Concepción
Blanco Carrera
Profesor/a Asociado/a en CC. de la Salud
![Foto de Concepción](/img/nophoto.png)
![Foto de Hospital Clinic Barcelona](/img/noimage_org.png)
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (14)
2024
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
-
Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas
Journal of Hypertension, Vol. 42, Núm. 2, pp. 252-259
2023
-
An Integrated CT and MRI Imaging Model to Differentiate between Adrenal Adenomas and Pheochromocytomas
Cancers, Vol. 15, Núm. 14
-
Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY
Journal of Endocrinological Investigation, Vol. 46, Núm. 4, pp. 805-814
-
Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?
Neuroendocrinology, Vol. 113, Núm. 6, pp. 657-666
-
Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas
Frontiers in Endocrinology, Vol. 14
-
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Frontiers in Endocrinology, Vol. 14
2022
-
Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas
Endocrine-related cancer, Vol. 29, Núm. 12, pp. 645-655
-
Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours
Scientific reports, Vol. 12, Núm. 1, pp. 2671
2021
-
Risk factors for intraoperative complications in pheochromocytomas
Endocrine-Related Cancer, Vol. 28, Núm. 11, pp. 695-703
-
Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY
Endocrine, Vol. 74, Núm. 3, pp. 676-684
2014
-
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study
Clinical Endocrinology, Vol. 81, Núm. 6, pp. 883-890
2013
-
Changes in acromegaly treatment over four decades in Spain: Analysis of the Spanish Acromegaly Registry (REA)
Pituitary, Vol. 16, Núm. 1, pp. 115-121